Tag: Chemotherapy
Nodal Response to Pre-Op Tx Tied to Survival in Esophageal Cancer
Survival benefit of nodal response maintained among patients with nodal, but not primary response
Chemo, Immunotherapy Feasible in Metastatic Bladder Cancer
One-year overall survival of 61 percent for gemcitabine and cisplatin plus ipilimumab
Leukemia, and Its Treatment, May Pose Neurocognitive Risks
Cerebrospinal fluid biomarkers may identify those at greater risk for poor neuro-related outcomes
3, 6 Month Adjuvant CAPOX Equally Effective for Colon Cancer
FOLFOX therapy for 6 months had higher disease-free survival rate compared to 3 months of treatment
ACC: Carvedilol Doesn’t Prevent Anthracycline Cardiotoxicity
Carvedilol does not prevent reduction in LVEF in breast cancer but is linked to lower troponin I levels
Private Insurance Coverage of Infused Chemo Varies by Setting
Better reimbursement at hospital outpatient depts, even though drug-level costs lower in doctor's office
Disparities Seen in Gastric Cancer Patients’ Receipt of Pre-Op Chemo
Racial, ethnic disparities in treatment also affect disparities in overall survival
Race, Education Level Predict CRT in Very Elderly With NSCLC
In elderly with stage III lung cancer, black race, lower-educated county tied to not receiving care
Cancer Therapies May Trigger Aging Phenotypes in Survivors
Chemotherapies, radiation have direct effects on telomere length, epigenetic modifications, microRNA
ASH: A+AVD Beats ABVD for Advanced Hodgkin’s Lymphoma
Lower combined risk of progression, death, or noncomplete response with A+AVD
